{"id":25444,"date":"2025-10-15T12:03:26","date_gmt":"2025-10-15T12:03:26","guid":{"rendered":"https:\/\/bmj-chicken.bmj.com\/thebmj\/the-bmj-article\/sodium-glucose-cotransporter-2-inhibitors-and-risk-of-autoimmune-rheumatic-diseases-population-based-cohort-study\/"},"modified":"2025-10-20T11:46:33","modified_gmt":"2025-10-20T11:46:33","slug":"sodium-glucose-cotransporter-2-inhibitors-and-risk-of-autoimmune-rheumatic-diseases-population-based-cohort-study","status":"publish","type":"the-bmj-article","link":"https:\/\/bmj-chicken.bmj.com\/thebmj\/the-bmj-article\/sodium-glucose-cotransporter-2-inhibitors-and-risk-of-autoimmune-rheumatic-diseases-population-based-cohort-study\/","title":{"rendered":"SGLT-2 inhibitors and risk of autoimmune rheumatic diseases"},"featured_media":0,"template":"","categories":[],"tags":[],"content_type":[36],"editorial_panel":[],"channel_page":[44],"class_list":["post-25444","the-bmj-article","type-the-bmj-article","status-publish","hentry","article-type-research","channel-page-research"],"aioseo_notices":[],"meta_box":{"the_bmj_article-url":"\/content\/391\/bmj-2025-085196","the_bmj_article-description":"SGLT-2 inhibitors were associated with an 11% lower risk of autoimmune rheumatic diseases compared with sulfonylureas, finds study ","the_bmj_article-the_bmj_article_image":[{"width":150,"height":150,"file":"2025\/10\/sglt_2_inhibitors_2YA1AGA.jpg","filesize":77073,"sizes":{"medium":{"file":"sglt_2_inhibitors_2YA1AGA-300x194.jpg","width":300,"height":194,"mime-type":"image\/jpeg","filesize":21196,"url":"https:\/\/bmj-chicken.bmj.com\/thebmj\/wp-content\/uploads\/sites\/4\/2025\/10\/sglt_2_inhibitors_2YA1AGA-300x194.jpg"},"thumbnail":{"file":"sglt_2_inhibitors_2YA1AGA-150x150.jpg","width":150,"height":150,"mime-type":"image\/jpeg","filesize":14693,"url":"https:\/\/bmj-chicken.bmj.com\/thebmj\/wp-content\/uploads\/sites\/4\/2025\/10\/sglt_2_inhibitors_2YA1AGA-150x150.jpg"}},"image_meta":{"aperture":"0","credit":"Alamy Stock Photo","camera":"","caption":"2YA1AGA Illustration of a sodium-glucose linked transporter 2 (SGLT2) protein (blue) with an inhibitor (red). SGLT2 is a transmembrane protein found in the nephrons of the kidney, where it functions to reabsorb glucose (sugar) from the urine to the blood. SGLT2 inhibitors suppress renal glucose reabsorption and so reduce blood glucose levels in patients with type 2 diabetes. SGLT2 inhibitors are therefore used as a treatment for type 2 diabetes.","created_timestamp":"0","copyright":"Credit: Science Photo Library \/ Alamy Stock Photo","focal_length":"0","iso":"0","shutter_speed":"0","title":"Illustration of a sodium-glucose linked transporter 2 (SGLT2) protein (blue) with an inhibitor (red). SGLT2 is a transmembrane protein found in the nephrons of the kidney, where it functions to reabsorb glucose (sugar) from the urine to the blood. SGLT2 i","orientation":"1","keywords":["Sodium-glucose","linked","transporter","2","with","inhibitor","illustration","3d","aging","alzheimer's","disease","artwork","biochemical","biochemistry","biological","biology","blood","sugar","cell","membrane","cgi","diabetes","digitally","generated","drug","flozin","glifozin","glucose","glucose","reabsorption","glucose","transporter","illustration","inhibiting","inhibitor","kidney","molecular","model","molecule","nephron","no-one","nobody","pharmacological","pharmacology","phospholipid","membrane","protein","renal","sglt2","sodium","glucose","linked","transporter","2","sodium-dependent","sodium-glucose","cotransporter","2","sodium-glucose","linked","transporter","2","structure","three","dimensional","transmembrane","sodium","glucose","cotransporter","2","transporter","treatment","type","2","diabetes"]},"ID":"25441","name":"sglt_2_inhibitors_2YA1AGA.jpg","path":"\/dom34810\/wp-content\/uploads\/sites\/4\/2025\/10\/sglt_2_inhibitors_2YA1AGA.jpg","url":"https:\/\/bmj-chicken.bmj.com\/thebmj\/wp-content\/uploads\/sites\/4\/2025\/10\/sglt_2_inhibitors_2YA1AGA-150x150.jpg","full_url":"https:\/\/bmj-chicken.bmj.com\/thebmj\/wp-content\/uploads\/sites\/4\/2025\/10\/sglt_2_inhibitors_2YA1AGA.jpg","title":"Illustration of a sodium-glucose linked transporter 2 (SGLT2) protein (blue) with an inhibitor (red). SGLT2 is a transmembrane protein found in the nephrons of the kidney, where it functions to reabsorb glucose (sugar) from the urine to the blood. SGLT2 i","caption":"2YA1AGA Illustration of a sodium-glucose linked transporter 2 (SGLT2) protein (blue) with an inhibitor (red). SGLT2 is a transmembrane protein found in the nephrons of the kidney, where it functions to reabsorb glucose (sugar) from the urine to the blood. SGLT2 inhibitors suppress renal glucose reabsorption and so reduce blood glucose levels in patients with type 2 diabetes. SGLT2 inhibitors are therefore used as a treatment for type 2 diabetes.","description":"","alt":"Illustration of a sodium-glucose linked transporter 2 (SGLT2) protein (blue) with an inhibitor (red)","srcset":false}],"the_bmj_article-related_articles":[],"the_bmj_article-journal_name":""},"head_tags":[{"tag":"title","content":"SGLT-2 inhibitors and risk of autoimmune rheumatic diseases | The BMJ"},{"tag":"meta","attributes":{"name":"robots","content":"max-image-preview:large"}},{"tag":"link","attributes":{"rel":"canonical","href":"https:\/\/bmj-chicken.bmj.com\/thebmj\/the-bmj-article\/sodium-glucose-cotransporter-2-inhibitors-and-risk-of-autoimmune-rheumatic-diseases-population-based-cohort-study\/"}},{"tag":"meta","attributes":{"name":"generator","content":"All in One SEO (AIOSEO) 4.9.7.1"}},{"tag":"meta","attributes":{"property":"og:locale","content":"en_GB"}},{"tag":"meta","attributes":{"property":"og:site_name","content":"The BMJ | The BMJ: leading general medical journal. Research. Education. Comment"}},{"tag":"meta","attributes":{"property":"og:type","content":"article"}},{"tag":"meta","attributes":{"property":"og:title","content":"SGLT-2 inhibitors and risk of autoimmune rheumatic diseases | The BMJ"}},{"tag":"meta","attributes":{"property":"og:url","content":"https:\/\/bmj-chicken.bmj.com\/thebmj\/the-bmj-article\/sodium-glucose-cotransporter-2-inhibitors-and-risk-of-autoimmune-rheumatic-diseases-population-based-cohort-study\/"}},{"tag":"meta","attributes":{"property":"article:published_time","content":"2025-10-15T12:03:26+00:00"}},{"tag":"meta","attributes":{"property":"article:modified_time","content":"2025-10-20T11:46:33+00:00"}},{"tag":"meta","attributes":{"name":"twitter:card","content":"summary"}},{"tag":"meta","attributes":{"name":"twitter:title","content":"SGLT-2 inhibitors and risk of autoimmune rheumatic diseases | The BMJ"}},{"tag":"link","attributes":{"rel":"alternate","type":"application\/rss+xml","title":"The BMJ \u00bb Feed","href":"https:\/\/bmj-chicken.bmj.com\/thebmj\/feed\/"}},{"tag":"link","attributes":{"rel":"alternate","type":"application\/rss+xml","title":"The BMJ \u00bb Comments Feed","href":"https:\/\/bmj-chicken.bmj.com\/thebmj\/comments\/feed\/"}},{"tag":"link","attributes":{"rel":"alternate","title":"oEmbed (JSON)","type":"application\/json+oembed","href":"https:\/\/bmj-chicken.bmj.com\/thebmj\/wp-json\/oembed\/1.0\/embed?url=https%3A%2F%2Fbmj-chicken.bmj.com%2Fthebmj%2Fthe-bmj-article%2Fsodium-glucose-cotransporter-2-inhibitors-and-risk-of-autoimmune-rheumatic-diseases-population-based-cohort-study%2F"}},{"tag":"link","attributes":{"rel":"alternate","title":"oEmbed (XML)","type":"text\/xml+oembed","href":"https:\/\/bmj-chicken.bmj.com\/thebmj\/wp-json\/oembed\/1.0\/embed?url=https%3A%2F%2Fbmj-chicken.bmj.com%2Fthebmj%2Fthe-bmj-article%2Fsodium-glucose-cotransporter-2-inhibitors-and-risk-of-autoimmune-rheumatic-diseases-population-based-cohort-study%2F&format=xml"}},{"tag":"link","attributes":{"rel":"https:\/\/api.w.org\/","href":"https:\/\/bmj-chicken.bmj.com\/thebmj\/wp-json\/"}},{"tag":"link","attributes":{"rel":"alternate","title":"JSON","type":"application\/json","href":"https:\/\/bmj-chicken.bmj.com\/thebmj\/wp-json\/wp\/v2\/the-bmj-article\/25444"}},{"tag":"link","attributes":{"rel":"EditURI","type":"application\/rsd+xml","title":"RSD","href":"https:\/\/bmj-chicken.bmj.com\/thebmj\/xmlrpc.php?rsd"}},{"tag":"meta","attributes":{"name":"generator","content":"WordPress 6.9.4"}},{"tag":"link","attributes":{"rel":"shortlink","href":"https:\/\/bmj-chicken.bmj.com\/thebmj\/?p=25444"}},{"tag":"meta","attributes":{"property":"og:locale","content":"en_GB"}},{"tag":"meta","attributes":{"property":"og:site_name","content":"The BMJ"}},{"tag":"meta","attributes":{"property":"og:title","content":"SGLT-2 inhibitors and risk of autoimmune rheumatic diseases"}},{"tag":"meta","attributes":{"property":"og:url","content":"https:\/\/bmj-chicken.bmj.com\/thebmj\/the-bmj-article\/sodium-glucose-cotransporter-2-inhibitors-and-risk-of-autoimmune-rheumatic-diseases-population-based-cohort-study\/"}},{"tag":"meta","attributes":{"property":"og:type","content":"article"}},{"tag":"meta","attributes":{"property":"og:description","content":"The BMJ: leading general medical journal. Research. Education. Comment"}},{"tag":"meta","attributes":{"name":"twitter:title","content":"SGLT-2 inhibitors and risk of autoimmune rheumatic diseases"}},{"tag":"meta","attributes":{"name":"twitter:url","content":"https:\/\/bmj-chicken.bmj.com\/thebmj\/the-bmj-article\/sodium-glucose-cotransporter-2-inhibitors-and-risk-of-autoimmune-rheumatic-diseases-population-based-cohort-study\/"}},{"tag":"meta","attributes":{"name":"twitter:description","content":"The BMJ: leading general medical journal. Research. Education. Comment"}},{"tag":"meta","attributes":{"name":"twitter:card","content":"summary_large_image"}}],"_links":{"self":[{"href":"https:\/\/bmj-chicken.bmj.com\/thebmj\/wp-json\/wp\/v2\/the-bmj-article\/25444","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bmj-chicken.bmj.com\/thebmj\/wp-json\/wp\/v2\/the-bmj-article"}],"about":[{"href":"https:\/\/bmj-chicken.bmj.com\/thebmj\/wp-json\/wp\/v2\/types\/the-bmj-article"}],"type":[{"embeddable":true,"href":"https:\/\/bmj-chicken.bmj.com\/thebmj\/wp-json\/wp\/v2\/types\/the-bmj-article"}],"wp:attachment":[{"href":"https:\/\/bmj-chicken.bmj.com\/thebmj\/wp-json\/wp\/v2\/media?parent=25444"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bmj-chicken.bmj.com\/thebmj\/wp-json\/wp\/v2\/categories?post=25444"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bmj-chicken.bmj.com\/thebmj\/wp-json\/wp\/v2\/tags?post=25444"},{"taxonomy":"article-type","embeddable":true,"href":"https:\/\/bmj-chicken.bmj.com\/thebmj\/wp-json\/wp\/v2\/content_type?post=25444"},{"taxonomy":"editorial-panel","embeddable":true,"href":"https:\/\/bmj-chicken.bmj.com\/thebmj\/wp-json\/wp\/v2\/editorial_panel?post=25444"},{"taxonomy":"channel-page","embeddable":true,"href":"https:\/\/bmj-chicken.bmj.com\/thebmj\/wp-json\/wp\/v2\/channel_page?post=25444"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}